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Abstract The hepatitis C virus internal ribosome entry site
(IRES) binds directly to the 40S ribosomal subunit via domains
III/IV while domain II induces conformational changes on the
ribosome which have been implicated in the decoding process.
Here, we performed an extensive mutational study within the
apical portion of domain II in order to address the functional role
of this region on translation. Our results showed that the
conservation of most nucleotides in this region was only partially
related to the IRES function. Notwithstanding, however, selected
single point mutations within the apical loop had a deleterious
effect on IRES activity. ß 2002 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
The hepatitis C virus (HCV) is the main causative agent of
post-transfusion non-A, non-B hepatitis [1]. In most infected
individuals, the virus establishes persistent infection, which
often leads to the development of chronic hepatitis, cirrhosis
and hepatocellular carcinoma [2]. HCV is an enveloped, sin-
gle-stranded, positive sense RNA virus classi¢ed within the
Flaviviridae family. The viral genome, about 9600 nucleotides
in length, encodes a polyprotein precursor which is processed
by viral and cellular proteases to yield mature viral proteins.
The open reading frame is £anked at the 5P and 3P ends by
highly structured non-translated regions (NTRs) [3]. Initiation
of translation of the HCV genome is controlled by an internal
ribosome entry site (IRES) located mainly within the 5PNTR
of the viral RNA [4^6]. The minimal sequence required for
IRES activity extends approximately from nucleotides 42
through 341 or 356, the 3P border being controversial [7^9].
This RNA segment is folded into a complex secondary struc-
ture consisting of several stem-loops, known as domains II,
III and IV, a pseudoknot and a helical structure that links
domain II with domains III and IV [10^13]. Both the highly
ordered structure and the nucleotide sequence of selected re-
gions of the IRES are critical in determining the IRES func-
tion [7,14^26]. Recent biochemical and biophysical studies
have shown that these elements form a unique tertiary struc-
ture that allows the direct binding of the 40S ribosomal sub-
unit at the site of the initiator AUG and the eIF3 through
multiple and speci¢c intermolecular contacts [15,18,22,27^33].
The RNA regions involved in these contacts have been
mapped mainly on domains III to IV, and the importance
of most interaction sites has been supported by mutational
analysis. On the other hand, domain II folds away from do-
mains III and IV and is not required for binding to the ribo-
some or to the eIF3 nor does it contribute to the a⁄nity of
these interactions [11,28,30]. Recent studies, however, have
shown that domain II induces a conformational change on
the 40S ribosomal subunit that has been implicated with the
RNA decoding process. A current model suggests that the
apical loop of domain II contacts ribosome at or near the E
site and may be involved in holding the coding RNA into the
decoding center until the translational machinery has as-
sembled [33]. Furthermore, sequence analysis studies have
shown that the apical unpaired regions of domain II contain
conserved nucleotide motifs which are also present in the cor-
responding IRES sequences from GBV-B and pestiviruses.
These include the motifs 81-ARCCA-85 (apical loop) and
71-GAA-73 and 92-UAGUA-96 (adjacent bulge) [9]. As the
overall sequence similarity within the 5PNTRs of those viruses
is low, the strong conservation of these motifs has suggested a
key role in translation initiation. Nevertheless, despite the
signi¢cance of those ¢ndings, the molecular details de¢ning
the role of domain II in IRES function remain elusive, since
the majority of the studies have focused on the structural
requirements of this region in the IRES-dependent translation
[9,23,34^36].
To elucidate the importance of the primary structure of the
apical region of domain II in the IRES function, we per-
formed an extensive mutational analysis and tested the e¡ects
of those mutations on the HCV IRES activity. Our results
con¢rmed the signi¢cance of the apical region of domain II
on translation and demonstrated that single-point mutations
at selected positions of the apical loop had a severe e¡ect on
IRES function. On the other hand, however, the integrity of
the conserved motifs was only partially related to the IRES
activity.
2. Materials and methods
2.1. Plasmids and site-directed mutagenesis
The dicistronic constructs pHPI933, pHPI1046 (Fig. 1E) and
pHPI892 were previously described [24,26]. Plasmid pHPI1121 was
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constructed by replacing the wild type HindIII^BstEII fragment of
pHPI1046 with the HindIII^BstEII fragment of pHPI892. Site-di-
rected mutagenesis was performed either by the M13-based MUTA-
GENE (Bio-Rad) or the Quikchange1 (Stratagene) kit using the oli-
gonucleotides shown in Table 1. All mutations were con¢rmed by
sequence analysis. M13-based mutagenesis was performed using the
plasmid pHPI803 as template [26]. Mutations were cloned into
pHPI933 by replacing the wild type 271 bp BamHI^NruI fragment
with the corresponding fragment of the mutated template. For the in
vivo studies, mutations were cloned into pHPI1046 by replacing the
wild type 1796 bp HindIII^BstEII fragment with the corresponding
fragment of the mutated pHPI933. Quikchange1 mutagenesis was
performed using the plasmid pHPI933 as template. All mutations
were recloned into pHPI933 by replacing the wild type 249 bp Bam-
HI^NheI fragment with the corresponding fragment of the mutated
template to assure that the vector had only the desirable mutation.
For the in vivo studies, mutations were cloned into the pHPI1046 by
replacing the wild type 1229 bp HindIII^XbaI fragment with the cor-
responding fragment of the mutated pHPI933.
2.2. In vitro transcription and translation
Wild type plasmids pHPI933 and pHPI892 (negative control) and
the mutated constructs (derived from pHPI933) were linearized with
XhoI. 2.5 Wg DNA from each plasmid was transcribed in vitro with
SP6 RNA polymerase. 400^500 ng of each uncapped RNA was used
for in vitro translation with Flexi Rabbit reticulocyte lysates (Prom-
ega). Transcription and translation reactions were performed as pre-
viously described [24,26].
2.3. Cells and DNA transfection experiments
HepG2 cells were maintained in minimum essential Eagle’s medium
(MEM; by Gibco BRL) supplemented with 10% fetal bovine serum
(MEM/FBS). Cells seeded in 6-well plates (40% con£uence) were
transfected with 1 Wg plasmid DNA using the lipofectamine plus
reagent (Boehringer Mannheim) according to the manufacturer’s
protocol. The medium was replaced with new MEM/FBS 24 h post-
transfection. At 48 h post-transfection the cells were washed twice
with phosphate-bu¡ered saline and lysed in 260 Wl Luciferase Lysis
Bu¡er 1X (Promega). Quantitation of ¢re£y luciferase (LUC) was
performed by mixing 20 Wl of cell extracts and 100 Wl luciferase
assay reagent (Promega) and the luminescence was directly mea-
sured by a Turner TD-20/20 luminometer. Quantitation of chloram-
phenicol acetyl transferase (CAT) was performed with the CAT^
ELISA kit (Boehringer Mannheim) according to the manufacturer’s
instructions. The ratio of LUC to CAT activities was estimated for
each mutation and compared with that of the wild type under the
constrain that the variability of the CAT amounts was lower or equal
to 40%.
Fig. 1. Predicted secondary structure of the upper segment of domain II of HCV IRES. Conserved bases are underlined (W.T., wild type).
A: Insertion and deletion mutations. B,C: Substitution mutations in the apical loop. D: Mutations a¡ecting the apical bulge and stem. Substi-
tution and insertion mutations are shown in bold. Deletion mutations are represented by triangles. E: Schematic representation of CAT^LUC
dicistronic constructs. The HCV-1a 5PNTR and 66 bases of the coding sequence are fused in frame with the LUC gene. In vitro and in vivo ex-
pression is mediated by SP6 and CMV promoter, respectively.
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3. Results
To investigate the functional role of the upper segment of
domain II in the IRES translation activity, we performed ex-
tensive site-directed mutational analysis in this region. The
sequence changes included insertion, deletion, and point mu-
tations (Fig. 1A^D). The e¡ect of each mutation, on IRES
driven translation, was assessed both in vitro and in vivo with
a dicistronic expression vector, which carries the CAT and the
LUC genes as the ¢rst and second cistron, respectively (Fig.
1E). Expression of LUC gene was directly related to the func-
tional properties of the HCV IRES, while the CAT activity
served as an internal control to correct possible di¡erences in
transfection e⁄ciencies in vivo or potential variations in the
transcript abundance in vitro. Fig. 2A^D (I) shows represen-
tative results of in vitro translation reactions. Fig. 2A^D (II)
shows the level of LUC expression relative to CAT expression
in transfected HepG2 cells. The results from the in vitro and
in vivo experiments (Fig. 2) were in close agreement and can
be summarized as follows:
1. Insertion and deletion mutations were introduced in the
apical loop of domain II to assess the importance of the
structure of this region to IRES function. Mutants K16
and K28 contain a 3-nucleotide insertion within the apical
loop next to nucleotides U-80 and U-86, respectively (Fig.
1A). Mutants K130, K131 and K132 have deletions of the
G-82, 82-GC-83 and 82-GCC-84 nucleotide sequences, re-
spectively (Fig. 1A). As shown in Fig. 2A, insertion muta-
tions caused a severe e¡ect on the expression of the LUC
gene, which was about 25% of that of the wild type. Addi-
tionally, all deletion mutations inhibited the IRES activity.
However, the LUC expression never reached the low levels
obtained from the insertion mutations, suggesting a di¡er-
ential sensitivity of the apical segment to the structural
constrains introduced by the di¡erent type of mutations.
Notably, the K132 mutation had the least e¡ect on trans-
lation. Our results were in agreement with previous studies
and indicated that the apical loop of domain II is essential
for IRES activity.
2. To assess the role of the nucleotide sequence of the apical
heptanucleotide loop on IRES function, a series of single
nucleotide substitutions were systematically introduced
into each one of the bases (Fig. 1B). As shown in Fig.
2B, these mutations a¡ected variably the IRES activity.
The most severe e¡ect resulted from substitutions in U-
80 and A-85 positions. Transversion (K99) and transition
(K100) mutations of U-80 as well as a transversion muta-
tion of A-85 (K14) almost completely abrogated IRES-
driven translation (Fig. 2B), indicating that the identity
of these nucleotides is particularly important for HCV
IRES activity. In contrast, changes in G-82 (K27) or U-
86 (K128, K129) had no detectable e¡ect on translation
(Fig. 2B), indicating that the nucleotide sequence of these
positions had no in£uence on IRES activity. Notably, de-
letion of G-82 (K130) resulted in a signi¢cant inhibition of
IRES function. On the other hand, changes of the highly
conserved nucleotides A-81, C-83 and C-84 (mutants K101,
Table 1
List of oligonucleotides and constructs used in the mutational analysis
Mutation Oligonucleotides In vitro plasmids In vivo plasmids
W.T. pHPI933 pHPI1046
N.C. pHPI892 pHPI1121
Single substitution mutations
K99 5P-71GAAAGCGTCAAGCCATGGCGTTAGTA-3P pHPI1105 pHPI1122
K100 5P-71GAAAGCGTCCAGCCATGGCGTTAGTA-3P pHPI1106 pHPI1123
K101 5P-71GAAAGCGTCTCGCCATGGCGTTAGTA-3P pHPI1107 pHPI1124
K27 5P-72AAAGCGTCTACCCATGGCGT-3P pHPI1004 pHPI1064
K102 5P-71GAAAGCGTCTAGGCATGGCGTTAGTA-3P pHPI1108 pHPI1125
K103 5P-71GAAAGCGTCTAGCGATGGCGTTAGTA-3P pHPI1109 pHPI1126
K104 5P-71GAAAGCGTCTAGCTATGGCGTTAGTA-3P pHPI1110 pHPI1127
K14 5P-77GTCTAGCCTTGGCGTTAGTATG-3P pHPI972 pHPI1072
K128 5P-71GAAAGCGTCTAGCCACGGCGTTAGTA-3P pHPI1114 pHPI1131
K129 5P-71GAAAGCGTCTAGCCAAGGCGTTAGTA-3P pHPI1115 pHPI1132
K29 5P-83CCATGGCGTTTGTATGAGTG-3P pHPI1005 pHPI1077
K15 5P-88GCGTTAGTTTGAGTGTCGTG-3P pHPI973 pHPI1062
K18 5P-89CGTTAGTAAGAGTGTCGTG-3P pHPI974 pHPI1063
Double substitution mutations
K124 5P-71GAAAGCGTCCAGCCACGGCGTTAGTA-3P pHPI1113 pHPI1130
K110 5P-65CACGCAGAAAACGCCTAGCCAT-3P pHPI1112 pHPI1129
K14^15 5P-77GTCTAGCCTTGGCGTTAGTATG-3P (¢rst) pHPI1117 pHPI1073
5P-88GCGTTAGTTTGAGTGTCGTG-3P (second)
K144 5P-71GAAAGCGTCAAGCCTTGGCGTTAGTA-3P pHPI1119 pHPI1136
5P-TACTAACGCCAAGGCTTGACGCTTTC-3P
K145 5P-71GAAAGCGTCCAGCCGTGGCGTTAGTA-3P pHPI1120 pHPI1137
5P-TACTAACGCCACGGCTGGACGCTTTC-3
Insertion mutations
K105 5P-71GAAAGCGTCCTGCCATGGGCGTTAGTA-3P pHPI1111 pHPI1128
K28 5P-71GAAAGCGTCTTTTAGCCATG-3P pHPI1034 pHPI1070
K16 5P-80TAGCCATGTAGGCGTTAGTATG-3P pHPI1041 pHPI1076
Deletion mutations
K130 5P-71GAAAGCGTCTA*CCATGGCGTTAGTA-3P pHPI1116 pHPI1133
K131 5P-71GAAAGCGTCTA**CATGGCGTTAGTA-3P pHPI1117 pHPI1134
K132 5P-71GAAAGCGTCTA***ATGGCGTTAGTA-3P pHPI1118 pHPI1135
W.T.: wild type; N.C.: negative control
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K102 and K103, K104) resulted in a moderate e¡ect, vary-
ing between 40 and 70% of the translation activity ob-
served with the wild type (Fig. 2B). These data showed
that the ¢rst (U-80) and sixth (A-85) bases of the apical
loop of domain II are critical, while the identity of the
remaining nucleotides is not essential for IRES activity.
Notably, U-86 in contrast to U-80 had no e¡ect on LUC
expression although U-80 and U-86 are both located at the
basis of the loop structure.
3. To investigate the importance of U-80 and A-85 in IRES
function, a series of double nucleotide substitutions were
introduced in the apical loop (Fig. 1C). Mutation K124
introduced a U-80-C and U-86-C double substitution in
order to examine the importance of having two identical
pyrimidines at the basis of the loop. Additionally, muta-
tions K144 and K145, each introducing a double nucleo-
tide substitution of U-80-A, A-85-U and U-80-C, A-85-G,
respectively, were designed to address the existence of a
putative Watson^Crick interaction between the bases U-
80 and A-85. K144 and K145 mutations test the possible
restoration of IRES activity from mutations K99 and
K100, respectively. However, none of those mutations
was able to fully restore the LUC production (Fig. 2C),
suggesting that the identity of U-80 and A-85 is critical for
IRES activity.
4. To further address the importance of the upper segment of
domain II on IRES function, a number of mutations were
introduced into the adjacent stem and bulge (Fig. 1D). In
the context of the terminal bulge, mutations K29 and K15
introduce an A-to-U change of the highly conserved A-93
and A-96, respectively, while mutation K18 carries a U-to-
A change of U-97. Mutations K15 and K18 did not sig-
ni¢cantly a¡ect the IRES activity, while mutation K29 had
a moderate e¡ect on IRES function (Fig. 2D). These data
suggest that similar to the case of the apical loop, the
identity of most bases of the upper bulge of domain II is
not absolutely essential for IRES function. Interestingly,
the double substitution mutation K14^15 that introduces
A-to-U changes at positions 96 and 85 of the apical part of
domain II (Fig. 1D), resulted in a complete inhibition of
the IRES activity (Fig. 2D). This emphasizes the impor-
tance of selected bases in the apical unpaired regions of
domain II on IRES function. In the context of the upper
stem, mutation K105 (Fig. 1D), which introduced an extra
GC base pair at the top of the stem, caused a moderate
e¡ect on IRES activity (Fig. 2D). In contrast, mutation
K110 (Fig. 1D), which introduced a double nucleotide sub-
stitution of G-75-A and U-78-C and was designed to create
a more stable base-pairing interaction within the upper
stem, did not alter IRES function (Fig. 2D). Thus, opti-
mizing the base pairing in the upper stem of domain II did
not appear to confer any translational advantage to the
IRES.
4. Discussion
In this study, we have employed an extensive mutational
analysis within the apical part of domain II in order to ad-
dress the functional role of this region on IRES-dependent
translation.
Our studies con¢rmed the structural importance of the ap-
ical stem-loop segment on the IRES function as insertion and
deletion mutations a¡ecting the secondary structure of this
region severely inhibited translation. On the other hand, our
data did not support an essential role on translation for the
previously identi¢ed conserved nucleotide motifs of the upper
segment of domain II [4,9]. Indeed, single nucleotide substi-
tutions of the conserved A-81, C-83, C-84 (apical loop), A-93,
A-96 (internal bulge) nucleotides had only moderate e¡ect on
translation e⁄ciency. Additionally, single changes of G-82
and U-86 had absolutely no e¡ect on IRES activity. Similarly,
it was recently reported that isolated small changes in the
upper single-stranded regions of domain II appeared to retain
IRES function [23,25]. Notably, similar results were reached
for the conserved pyrimidine-rich motifs of the apical loop of
domain III [13].
On the other hand, single nucleotide substitutions of U-80
and A-85 strongly inhibited the IRES activity. Interestingly,
these mutations had a more severe e¡ect on translation than
the previously described deletion mutations. Furthermore,
mutation K14^15 that alters A-85 and A-96 to uridines com-
pletely abolished IRES function. Whether these nucleotides
represent a sequence- or a structural-speci¢c element is cur-
rently unknown. However, a series of double nucleotide sub-
stitutions (mutations K144, K145) designed to maintain a
putative Watson^Crick interaction between positions 80 and
85 failed to restore IRES function. Additionally, mutation
K124, designed to maintain two identical pyrimidines at the
basis of the apical loop, restored only marginally the IRES
activity. Furthermore, mutations K99 and K129 revealed op-
posing e¡ects on the IRES function despite the fact that each
of them is predicted to a¡ect similarly the secondary structure
of the apical loop. Thus, taken together these results suggested
that, in addition to the secondary structure, selected bases of
the apical loop are critical for the viral RNA translation. On
the other hand, the integrity of the conserved nucleotide mo-
tifs in the apical segment of domain II was not found essential
for IRES function, at least in the context of the dicistronic
vector.
It is of interest to note that the most critical nucleotides for
IRES activity, U-80 and A-85, are accessible to solvent upon
40S ribosomal subunit binding, in contrast to the least critical
bases for IRES function, G-82 and U-86 [30]. Therefore, the
strong inhibitory e¡ect caused by mutations at positions 80
and 85 may suggest a possible contribution of those bases to
the viral RNA decoding process. Because of the high degree
of sequence conservation of the apical region of domain II in
6
Fig. 2. I: In vitro translation activity from reticulocyte lysates programmed with equal amounts of dicistronic RNAs containing HCV IRES
mutant variants. The in vitro translation products (identi¢ed on the left) were separated on SDS^PAGE and analyzed by autoradiography. II:
In vivo translation activities of HCV IRES variants in the context of the dicistronic constructs. Duplicate cultures of HepG2 cells were trans-
fected with plasmids containing the mutated IRESs and the activity of each mutation was calculated by determining the ratio of LUC to CAT
activity. Bars represent the means obtained in three to ¢ve separate experiments of duplicate cultures. Error bar represents the standard devia-
tion. Insertions, deletions (A) and single substitutions (B) within the apical loop. Double substitutions within the apical loop (C) and mutations
within the internal bulge and the upper stem (D). W.T., wild type; N.C., negative control; MOCK, no RNA (in vitro) or DNA (in vivo)
added.
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diverse viral IRES sequences, it is tempting to speculate that
this region may still play a key role on IRES function, other
than its direct interaction with the basic translation machin-
ery. One such possibility could be at the level of regulation
of the IRES activity through novel RNA^RNA or RNA^
protein interactions. Indeed, recent studies have shown that
the HCV IRES activity is cell cycle dependent [37]. Most
importantly, domain II is proposed to adopt di¡erent confor-
mations within the IRES structure via the £exible unstruc-
tured region that joins domain II with III/IV [11,26].
Although experimental data are still lacking, we would like
to propose that the apical part of domain II alone or together
with the £exible unstructured region, may represent part of a
regulatory switch for the IRES function. Further work is re-
quired to test this hypothesis.
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